Flagyl Tablets (Metronidazole 200mg & 400mg) | Broad-Spectrum Antibiotic & Antiprotozoal Therapy for Anaerobic Infections

Product Description

Product Overview and Introduction

Target stubborn anaerobic pathogens and parasitic infections with precision using Flagyl Tablets (Metronidazole 200mg & 400mg). As a flagship prescription nitroimidazole-class antimicrobial medication, Flagyl is trusted worldwide by healthcare professionals to treat a wide array of serious clinical conditions, including gastrointestinal infections, bacterial vaginosis, pelvic inflammatory disease, intra-abdominal abscesses, and dental infections. Engineered to thrive in oxygen-depleted environments, Flagyl provides aggressive microbicidal action against organisms that survive where traditional aerobic antibiotics fail.

At the core of Flagyl is metronidazole, a potent synthetic antimicrobial agent that disrupts essential microbial nucleic acid synthesis. Once absorbed into susceptible anaerobic bacteria or protozoa, the drug’s nitro group is chemically reduced by intracellular electron transport proteins. This reduction creates reactive intermediate compounds that bind to and damage microbial DNA, halting replication and effectively eradicating the infection at its cellular foundation.

Key Engineering and Clinical Highlights

Manufactured under strict pharmaceutical controls to ensure high bioavailability, systemic tissue penetration, and consistent potency, Flagyl delivers rigorous clinical performance:

• Targeted Anaerobic Efficacy: Specifically formulated to seek out and destroy anaerobic bacteria and select protozoal parasites (such as Trichomonas and Giardia).

• High Systemic Bioavailability: Rapidly absorbs through the gastrointestinal tract and distributes deeply into body tissues, cerebrospinal fluid, and abscess cavities.

• Intracellular DNA Disruption: Chemical reduction mechanism selectively targets anaerobic microbial pathways while sparing human host cells.

• Flexible Dosage Strengths: Available in both 200mg and 400mg formulations to accommodate precise clinical protocols and multi-day treatment courses.

The Definitive Standard in Anaerobic and Protozoal Care

When clinical diagnostics and medical protocols require a specialized antimicrobial capable of overcoming oxygen-independent pathogens and complex systemic challenges, Flagyl stands out as an indispensable therapeutic standard.

Key Features and Benefits

• Targeted Pathogen Control: Highly effective for clearing persistent protozoal infections, anaerobic abdominal abscesses, and bacterial vaginosis.

• Proven Clinical Efficacy: Decades of global medical usage backed by well-established safety, pharmacokinetic profiles, and dosing guidelines.

Specifications

• Product Type: Prescription Broad-Spectrum Antibiotic & Antiprotozoal Agent

• Active Ingredient: Metronidazole (Available in 200mg and 400mg oral tablets)

• Indication: Treatment of Anaerobic Bacterial Infections, Bacterial Vaginosis, Giardiasis, Trichomoniasis, and Amoebiasis

• Packaging: Pharmaceutical Blister Packs or Dispensing Bottles (Quantity varies by prescription)

• Administration Route: Oral Tablet

• Condition: Brand New Pharmaceutical Grade (Requires Prescription)

Additional Information